{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T12:23:50Z","timestamp":1789388630985,"version":"build-2803163510"},"reference-count":23,"publisher":"SAGE Publications","issue":"3","license":[{"start":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T00:00:00Z","timestamp":1687305600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Ann Pharmacother"],"published-print":{"date-parts":[[2024,3]]},"abstract":"<jats:p>Treatment options for moderate-to-severe psoriasis depend on drug efficacy and safety, patient preferences, comorbidities, and cost\u2014no drug dominates across all dimensions. Interleukin (IL)-17 inhibitors may be preferred for fast-acting treatment, while the 3-month schedule of risankizumab, ustekinumab, or tildrakizumab may be attractive for patients who prioritize fewer injections. Phototherapy is suitable for patients who wish to avoid systemic agents or when cost is a concern. For patients with poor adherence, infliximab or tildrakizumab may be well suited as they require in-office administration. Dermatologists can educate patients on available therapies to find a regimen best suited to their needs.<\/jats:p>","DOI":"10.1177\/10600280231170031","type":"journal-article","created":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T06:50:00Z","timestamp":1687330200000},"page":"333-337","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":4,"title":["Choosing Systemic Agents for Psoriasis"],"prefix":"10.1177","volume":"58","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0715-9204","authenticated-orcid":false,"given":"Christina","family":"Kontzias","sequence":"first","affiliation":[{"name":"Center for Dermatology Research, Department of Dermatology, Wake Forest University School of Medicine, Winston-Salem, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rithi","family":"Chandy","sequence":"additional","affiliation":[{"name":"Center for Dermatology Research, Department of Dermatology, Wake Forest University School of Medicine, Winston-Salem, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven R.","family":"Feldman","sequence":"additional","affiliation":[{"name":"Center for Dermatology Research, Department of Dermatology, Wake Forest University School of Medicine, Winston-Salem, NC, USA"},{"name":"Department of Pathology, Wake Forest University School of Medicine, Winston-Salem, NC, USA"},{"name":"Department of Social Sciences and Health Policy, Wake Forest University School of Medicine, Winston-Salem, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2023,6,21]]},"reference":[{"key":"bibr1-10600280231170031","doi-asserted-by":"publisher","DOI":"10.1177\/10600280231153863"},{"key":"bibr2-10600280231170031","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-019-00337-y"},{"key":"bibr3-10600280231170031","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2013.07.023"},{"key":"bibr4-10600280231170031","doi-asserted-by":"publisher","DOI":"10.1111\/ijd.14246"},{"key":"bibr5-10600280231170031","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.06.057"},{"key":"bibr6-10600280231170031","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2022.2140569"},{"key":"bibr7-10600280231170031","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.11.058"},{"key":"bibr8-10600280231170031","doi-asserted-by":"publisher","DOI":"10.3390\/ijms231911128"},{"key":"bibr9-10600280231170031","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2018.06.056"},{"key":"bibr10-10600280231170031","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-007-0590-5"},{"key":"bibr11-10600280231170031","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-019-00435-9"},{"key":"bibr12-10600280231170031","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21051690"},{"key":"bibr13-10600280231170031","unstructured":"Feldman SR. Treatment of psoriasis in adults. UpToDate. Updated October 12, 2022. Accessed December 10, 2022. https:\/\/www.uptodate.com\/contents\/treatment-of-psoriasis-in-adults#H203452107"},{"key":"bibr14-10600280231170031","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-016-0211-7"},{"key":"bibr15-10600280231170031","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.16521"},{"key":"bibr16-10600280231170031","doi-asserted-by":"publisher","DOI":"10.1161\/CIR.0000000000000950"},{"key":"bibr17-10600280231170031","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2021.1970706"},{"issue":"3","key":"bibr18-10600280231170031","first-page":"305","volume":"15","author":"James SM","year":"2016","journal-title":"J Drugs Dermatol"},{"key":"bibr19-10600280231170031","doi-asserted-by":"publisher","DOI":"10.1080\/09546634.2019.1698700"},{"key":"bibr20-10600280231170031","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.04.095"},{"issue":"1","key":"bibr21-10600280231170031","first-page":"18","volume":"10","author":"Hyde K","year":"2018","journal-title":"Am J Pharm Benefits"},{"key":"bibr22-10600280231170031","doi-asserted-by":"publisher","DOI":"10.1007\/s00403-022-02410-7"},{"key":"bibr23-10600280231170031","unstructured":"Levinson DR. Manufacturer safeguards may not prevent copayment coupon use for part D drugs. 2014. Accessed March 22, 2023. https:\/\/oig.hhs.gov\/oei\/reports\/oei-05-12-00540.pdf"}],"container-title":["Annals of Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10600280231170031","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/10600280231170031","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/10600280231170031","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:13:10Z","timestamp":1777374790000},"score":1,"resource":{"primary":{"URL":"http:\/\/journals.sagepub.com\/doi\/10.1177\/10600280231170031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,21]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["10.1177\/10600280231170031"],"URL":"https:\/\/doi.org\/10.1177\/10600280231170031","relation":{},"ISSN":["1060-0280","1542-6270"],"issn-type":[{"value":"1060-0280","type":"print"},{"value":"1542-6270","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,21]]}}}